Novartis News
Most Popular Novartis Story
Novartis recall hints at regulatory snowball
Uh-oh. Novartis ($NVS) is recalling some OTC drugs made at a Nebraska plant that was recently shut down for maintenance and upgrades. The voluntary recall is one thing. But the recall's timing, so Read more...
Latest Headlines
- January 31, 2012
- January 19, 2012
- January 16, 2012
- January 9, 2012
- January 4, 2012
- January 3, 2012
- December 21, 2011
- December 14, 2011
- December 7, 2011
- November 17, 2011
- November 1, 2011
- October 25, 2011
- July 7, 2011
- June 19, 2011
- June 8, 2011
- January 25, 2011
- November 10, 2010
- November 3, 2010
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
